Article Link: Bayer Receives FDA Approval for Jivi (antihemophilic factor (recombinant), PEGylated-aucl) for Prophylactic Treatment of Hemophilia A�...
Tetraphase Pharmaceuticals Announces FDA Approval of Xerava (eravacycline) for Complicated Intra-Abdominal Infections (cIAI)
Article Link: Tetraphase Pharmaceuticals Announces FDA Approval of Xerava (eravacycline) for Complicated Intra-Abdominal Infections (cIAI) ...
FDA Approves Imbruvica (ibrutinib) Plus Rituximab for Patients with Waldenström’s Macroglobulinemia
Article Link: FDA Approves Imbruvica (ibrutinib) Plus Rituximab for Patients with Waldenström’s Macroglobulinemia HORSHAM, Pa., August 27...
Ortho Dermatologics Receives FDA Approval for Altreno (tretinoin 0.05%) Lotion For Acne
Article Link: Ortho Dermatologics Receives FDA Approval for Altreno (tretinoin 0.05%) Lotion For Acne LAVAL, Quebec, Aug. 24, 2018 /PRNew...
FDA Approves Takhzyro (lanadelumab-flyo) for Hereditary Angioedema
Article Link: FDA Approves Takhzyro (lanadelumab-flyo) for Hereditary Angioedema August 23, 2018 — The U.S. Food and Drug Administr...
FDA Approves Inveltys (loteprednol etabonate) for Post-Operative Inflammation and Pain Following Ocular Surgery
Article Link: FDA Approves Inveltys (loteprednol etabonate) for Post-Operative Inflammation and Pain Following Ocular Surgery WALTHAM, Ma...
FDA Approves Oxervate (cenegermin) for Neurotrophic Keratitis
Article Link: FDA Approves Oxervate (cenegermin) for Neurotrophic Keratitis August 22, 2018 — The U.S. Food and Drug Administration...
FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome
Article Link: FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome On August 20, 2018, the U.S. Food and Drug...
FDA Approves New Eylea (aflibercept) Injection Dosing Schedule in Wet Age-Related Macular Degeneration
Article Link: FDA Approves New Eylea (aflibercept) Injection Dosing Schedule in Wet Age-Related Macular Degeneration TARRYTOWN, N.Y., Aug...
FDA Approves Opdivo (nivolumab) for Certain Patients with Previously Treated Small Cell Lung Cancer
Article Link: FDA Approves Opdivo (nivolumab) for Certain Patients with Previously Treated Small Cell Lung Cancer PRINCETON, N.J.–(...
